Navigation Links
H. D. Smith Voices Support for the Fairness in Medicare Bidding Act
Date:7/11/2011

SPRINGFIELD, Ill., July 11, 2011 /PRNewswire-USNewswire/ -- H. D. Smith, among the nation's largest pharmaceutical wholesalers, today announced its support for H.R. 1041, also known as the Fairness in Medicare Bidding Act. Introduced by Representatives Jason Altmire (D-PA) and Glenn Thompson (R-PA), the bill seeks to repeal the Medicare Durable Medical Equipment Prosthetics, Orthotics and Supplies (DMEPOS) competitive bidding program included in the Medicare Modernization Act of 2003 (MMA).

The DMEPOS program created as part of MMA sought to reduce the Medicare excess product cost while assuring beneficiary access to quality care providers. However; the program's unclear standards have impacted negatively competition among home medical equipment suppliers (HME). Since its passage, MMA has led to fewer HME marketplace competitors, a decrease in patient access and quality care and created the potential for additional strain on the Medicare system.

The Fairness in Medicare Bidding Act has been referred to the House Energy and Commerce, House Appropriations and House ways and Means Committees.

"We applaud the efforts of Representatives Altmire and Thompson in introducing this legislation that will help ensure marketplace competition, patient access and quality of care for home medical equipment suppliers and consumers," said Ron Lanton, Government Affairs Counsel, H. D. Smith. "H.R. 1041 provides a common sense solution to ensure an open and fair marketplace that can provide patients the healthcare options they need for their medical care and quality of life."

About H. D. Smith

Headquartered in Springfield, Illinois, H. D. Smith is among the largest national full-line, full-service wholesalers providing a complete line of pharmaceuticals, OTCs, HBAs, home healthcare products, durable medical equipment, seasonal merchandise and a wide array of marketing programs to retail pharmacies, regional chains and health systems. The company has distribution facilities in California, Florida, Kentucky, Illinois, New Hampshire, New Jersey and Texas that service major markets throughout the United States.  Additional information about H. D. Smith can be found at hdsmith.com.

Contact:
Allison Worrell
H. D. Smith
Marketing Communications Manager
217-753-1688
aworrell@hdsmith.com

Mark Marmur
Makovsky + Company, Inc.
Assistant Vice President
212-508-9670
mmarmur@makovsky.com


'/>"/>
SOURCE H. D. Smith
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Receives FDA Approval for BOOSTRIX® to Help Prevent Whooping Cough in Adults 65 Years and Older
2. H. D. Smith Appoints Mark de Bruin Corporate Vice President Managed Care
3. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
4. Smith & Nephew Inc. Acquires Privately-Held TENET Medical Engineering, Inc.; Premier Provider of Surgical Patient Positioning Equipment
5. Smith & Nephew Endoscopy Awarded $85 Million in Patent Infringement Case Against Arthrex, Inc.
6. Upsher-Smith Receives Prestigious DIANA Award for Third Year in a Row
7. Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys
8. GlaxoSmithKline Confirms allis Safety Profile
9. Talyst Signs Vendor Agreement With H. D. Smith to Provide Quality- and Patient Safety-Enhancing Pharmacy Automation Solutions
10. Smith & Nephews TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids
11. Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Wegener Polyangiitis - Pipeline Review, H2 ... Polyangiitis - Pipeline Review, H2 2015, provides an ... This report provides comprehensive information on the therapeutic ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ...
(Date:2/4/2016)... Frontier Pharma: Chronic Obstructive Pulmonary Disease ... Chronic Obstructive Pulmonary Disease (COPD) is ... the airways and lungs. Persistent breathing difficulties and ... one of the leading causes of morbidity and ... COPD is linked to cumulative exposure to risk ...
(Date:2/4/2016)... 2016 In response to the opioid abuse epidemic, ... for Medical Products and Tobacco, along with other FDA leaders, ... approach to opioid medications. The plan will focus on policies ... pain access to effective relief. --> ... Re-examine the risk-benefit paradigm for opioids and ensure that the ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at King Kullen! ... assortments and packaging. This staple for Valentine’s Day is a must-have, and can be ... Valentine’s Day, not only are long-stem roses available, but also other flower bouquets, elegantly ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... of Popeyes Louisiana Kitchen restaurants, launched the 14th annual “Appetite for a Cure” ... adults with muscular dystrophy, ALS and related diseases that severely limit strength and ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... poised to once again host, Swirl, A Wine Tasting Event at the La ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced ... and donate to Give To Cure’s campaign that is crowdfunding clinical trials to help ... and share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion ...
(Date:2/5/2016)... ... 2016 , ... Stuart Bentkover, MD, FACS is thrilled to announce ... most effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts ... PicoSure has been approved by the Food and Drug Administration (FDA) as a safe ...
Breaking Medicine News(10 mins):